查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1864727

依產品類型、技術、最終用戶、通路、適應症和年齡層分類的管腔成形術市場－2025-2032年全球預測

Canaloplasty Market by Product Type, Technique, End User, Distribution Channel, Indication, Age Group - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，根管成形術市場將成長至 9.8748 億美元，複合年成長率為 7.49%。

關鍵市場統計數據
基準年 2024 5.5404億美元
預計年份：2025年 5.9484億美元
預測年份 2032 9.8748億美元
複合年成長率 (%) 7.49%

臨床和商業性概覽，將小管成形術定位為一個“手術生態系統”，它透過各種設備、技術和臨床環境重塑青光眼治療模式。

在手術技術創新和臨床醫生技能不斷提高的推動下，小管成形術已成為青光眼治療新範式的核心。該領域結合了精密的顯微外科技術和基於器械的治療方法，旨在恢復生理性房水流出，同時減少對長期藥物的依賴。因此，臨床醫生和醫療系統正日益探索小管成形術作為傳統濾過手術和現代微創手術之間橋樑的潛力。

器材工程技術的進步、微創技術的普及以及醫療保健服務體系的重新設計，是如何重新定義管腔成形術的實踐和商業化的？

近年來，技術改進、流程標準化和相關人員的協作共同創造了新的機遇，並推動了變革性變化，重新定義了小管成形術的實踐和商業化。微導管設計的創新提高了管腔導航和擴充性的準確性，手術包中也擴大包含最佳化的黏彈性物質，以實現可預測的組織行為並確保手術結果的可重複性。這些產品層面的進步與「內路」（從眼內入路）微創手術方法的轉變相輔相成，這些方法減少了手術創傷，擴大了適用患者群體，並加快了患者的康復速度，同時降低了資源消耗。

評估美國近期關稅調整如何影響運河化相關人員的供應鏈選擇、製造策略和商業性動態

2025年美國關稅政策的實施，為眼科器械製造商和經銷商的全球供應鏈帶來了新的限制和獎勵。部分醫療設備和零件進口關稅的調整，迫使製造商重新評估籌資策略，調整其製造地的區域佈局，並加快供應商多元化，以降低成本風險。這些變化也影響著經銷商的定價策略，以及原始設備製造商（OEM）經銷商和增值轉售商之間的談判動態。這些經銷商必須在維持服務水準的同時，應對利潤壓力。

策略性細分洞察揭示了產品類型、流程、終端用戶環境、通路、臨床適應症和年齡層如何相互作用，從而決定臨床應用和商業性重點。

詳細的細分分析揭示了哪些產品類型和手術方法正在影響臨床醫生的偏好和購買行為。微導管產品的創新提高了管腔內導航和輸送精度，而整合式手術套件的普及則簡化了術中工作流程並減少了設定差異。黏彈性物質在血管成形術中發揮關鍵作用，凸顯了黏彈性物質（包括凝聚型和分散型）之間的臨床差異。凝聚型黏彈性物質有助於在一次手術中完成管腔擴張和清除，而分散型黏彈性物質則在複雜的解剖結構中提供更好的組織保護，從而影響臨床醫生根據病例特徵做出的選擇。

區域比較評估重點在於報銷框架、臨床基礎設施和分銷生態系統在哪些方面對通路化採用和供應商策略的影響最大。

區域趨勢差異顯著，這將影響投資、臨床教育和供應鏈最佳化在哪些地區能發揮最大作用。在美洲，成熟的報銷系統和完善的門診手術基礎設施促進了微創耳道成形術的快速普及，但該地區面臨著集中的成本壓力，促使採購轉向捆綁式解決方案和經濟高效的耗材。歐洲、中東和非洲地區的情況則更為複雜。雖然一些歐洲市場擁有先進的監管路徑和廣泛的手術應用，但中東和北非地區湧現一些新興的卓越中心，這些中心優先考慮培訓和技術轉移項目，並致力於提升本地能力。與當地經銷商合作並投資臨床醫生教育，將是擴大這些地區手術量的關鍵。

競爭格局和夥伴關係模式區分了成熟的多產品系列公司、專業創新者和推動根管成形術普及和規模化的通路夥伴。

競爭格局呈現出兩極化的特點：既有擁有廣泛眼科產品組合的成熟醫療設備公司，也有專注於微創青光眼手術技術的專業創新企業。成熟企業利用臨床試驗網路、外科醫生培訓計畫和一體化服務模式來維護高價值客戶，並將自身定位為提供全面手術解決方案的供應商。同時，專業製造商則專注於差異化的導管設計、一次性手術包或新型黏彈性化學物質，以獲得臨床認可，並在早期採用者中建立高階市場地位。

針對製造商和通路合作夥伴，制定可操作的策略重點，重點在於證據產生、適應性商業模式和彈性供應鏈設計，以加速產品推廣應用。

為維持發展勢頭，產業領導者應優先考慮臨床證據的累積、供應鏈的韌性以及差異化的商業模式。投資前瞻性註冊研究和合作性真實世界證據計畫將有助於檢驗不同適應症的療效，包括原發性開放性青光眼和難治性次發性青光眼，例如新生血管性青光眼和色素性青光眼。這些努力應與有針對性的臨床醫生教育舉措相結合，重點強調外側入路和內側入路的技術差異，以及選擇黏彈性物質（黏性與分散性）的實際意義。

本分析的調查方法架構是基於對主要臨床醫生和相關人員的訪談，並輔以二級監管和臨床文獻審查以及多軸分割分析。

本分析的調查方法結合了定性和定量方法，旨在深入了解小梁成形術的發展趨勢。主要研究包括對青光眼外科醫生、門診手術中心管理人員、醫院採購負責人和分銷合作夥伴進行結構化訪談，以獲取有關手術選擇、器械偏好和服務期望的第一手資訊。這些訪談輔以二手研究，後者整合了監管指南、手術編碼系統和已發表的臨床文獻，以三角檢驗臨床應用的促進因素並對器械屬性進行比較驗證。

策略整合凸顯了將管腔成形術的臨床創新轉化為永續臨床應用的關鍵需求，包括證據、訓練和營運韌性。

摘要，管腔成形術處於器械創新、手術流程演進和醫療服務模式變革的交匯點，所有這些都對製造商、經銷商和臨床機構產生了重大的戰略影響。在這種格局下，能夠將可靠的臨床證據、臨床醫生培訓和靈活的商業管道相結合，同時保持供應鏈的適應性，並應對貿易政策變化和區域監管的複雜性，將有利於那些能夠做到這一點的機構。產品差異化，尤其是在微導管性能、手術包設計和黏彈性特性方面的差異化，將繼續影響臨床醫生的選擇和手術的採用。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將微創小梁成形術與微創青光眼手術 (MIGS) 結合，以降低青光眼患者的眼內壓
  • 開發永續黏彈性植入可改善管腔重塑並實現長期眼內壓控制。
  • 引入先進的影像引導導航系統將提高管腔成形術的精確度。
  • 專注於微創管成形術技術的醫生培訓計畫的激增，提高了該技術的採用率。
  • 增加血管成形術後藥物釋放型支架的投資，以預防術後纖維化並維持管腔通暢性。
  • 醫療器械製造商與學術機構之間日益密切的合作推動了血管成形術器械和材料的創新。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的根管成形術市場

  • 微導管
  • 手術包
  • 黏彈性劑
    • 內聚黏彈性劑
    • 分散型黏彈性劑

9. 按技術分類的管腔成形術市場

  • 體外循環法
  • 從眼睛內部
    • 微創方法

第10章 依最終用戶分類的管腔成形術市場

  • 門診手術中心
    • 附屬設施
    • 獨立中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 眼科診所
    • 連鎖診所
    • 獨立診所

第11章 依分銷管道分類的根管成形術市場

  • 直銷
  • 透過分銷商銷售
    • OEM分銷商
    • 增值轉售商

第12章 依適應症分類的管腔成形術市場

  • 原發性開放性青光眼
  • 續發性青光眼
    • 新生血管性青光眼
    • 色素性青光眼

第13章 依年齡層別分類的耳蝸成形術市場

  • 成人
  • 老年人
  • 兒童

第14章 各地區耳蝸成形術市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 管腔成形術市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國管腔成形術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Nova Eye Medical, Inc.
    • Sight Sciences, Inc.
    • Glaukos Corporation
    • Sight Sciences, Inc.
    • Ellex Medical Lasers Limited
Product Code: MRR-8958E923A70E

The Canaloplasty Market is projected to grow by USD 987.48 million at a CAGR of 7.49% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 554.04 million
Estimated Year [2025] USD 594.84 million
Forecast Year [2032] USD 987.48 million
CAGR (%) 7.49%

A clinical and commercial overview that positions canaloplasty as a procedural ecosystem reshaping glaucoma care delivery across devices, techniques, and care settings

Canaloplasty has emerged as a focal point in the evolving treatment paradigm for glaucoma, driven by procedural innovation and expanding clinician familiarity. The field blends refined micro-surgical techniques with device-enabled approaches that aim to restore physiologic aqueous outflow while reducing reliance on chronic pharmacotherapy. As a result, clinicians and health systems are increasingly exploring canaloplasty as a bridge between traditional filtration surgeries and modern microinvasive options.

This introduction frames canaloplasty not simply as a procedure, but as an ecosystem comprising specialized instruments such as microcatheters, integrated surgical kits, and supporting viscoelastic agents designed to facilitate trabecular and Schlemm's canal interventions. The technique portfolio spans Ab Externo approaches to Ab Interno microinvasive procedures, and the treatment is being adopted across care settings from ambulatory surgical centers to hospital operating theaters and dedicated ophthalmology clinics. Understanding these dynamics is essential for stakeholders seeking to prioritize product roadmaps, refine commercial models, and align clinical evidence generation with payer and provider expectations.

How concurrent advances in device engineering, microinvasive technique adoption, and care delivery redesign are converging to redefine canaloplasty practice and commercialization

Recent years have witnessed transformative shifts that are redefining how canaloplasty is practiced and commercialized, with technological refinement, procedural standardization, and stakeholder alignment converging to create new opportunities. Innovation in microcatheter design has improved navigation and dilation of the canal, while surgical kits are increasingly bundled with optimized viscoelastic agents that deliver predictable tissue behavior and facilitate reproducible outcomes. These product-level advances are complemented by a shift toward Ab Interno microinvasive approaches that reduce surgical trauma and expand the candidate pool by enabling faster recovery and lower resource utilization.

Concurrently, payer perceptions and hospital credentialing practices are evolving. Real-world evidence demonstrating the potential to reduce medication burden and improve intraocular pressure stability has supported more streamlined coverage pathways in certain jurisdictions. Additionally, care delivery is shifting toward ambulatory surgical centers and specialized ophthalmology clinics that can perform high volumes of minimally invasive procedures. These centers are investing in training, device inventories, and protocol standardization, accelerating diffusion and creating a competitive environment in which suppliers must demonstrate both clinical value and operational efficiency.

Assessment of how recent United States tariff adjustments have reshaped supply chain choices, manufacturing strategies, and commercial dynamics for canaloplasty stakeholders

The tariffs implemented by the United States in 2025 introduced a new set of constraints and incentives that ripple across global supply chains serving ophthalmic device manufacturers and distributors. Tariff adjustments on certain medical devices and component imports have compelled manufacturers to reassess sourcing strategies, reconsider regional manufacturing footprints, and accelerate supplier diversification to mitigate cost exposure. In turn, these shifts have influenced distributor pricing strategies and the negotiation dynamics between Original Equipment Distributors and value added resellers, who must manage margin pressure while preserving service levels.

Beyond procurement, the tariff environment affected investment timing and capital allocation decisions. Some established manufacturers accelerated local assembly or sought contractual toll-manufacturing arrangements within tariff-favored jurisdictions to preserve competitiveness. Conversely, smaller specialized device firms faced tighter windows to absorb incremental cost without compromising commercial momentum, prompting some to prioritize high-value product lines and strategic partnerships. As a result, clinicians and institutional purchasers observed subtle shifts in product availability, promotional support, and post-market service offerings, reinforcing the importance of resilient supply chain design and adaptive commercial models in the face of trade policy volatility.

Strategic segmentation insights revealing how product types, procedural techniques, end-user settings, distribution routes, clinical indications, and age cohorts jointly determine clinical adoption and commercial focus

A granular segmentation lens reveals which product categories and procedural approaches are shaping clinician preference and purchasing behavior. Product innovations in microcatheters have improved canal navigation and delivery precision, while the proliferation of integrated surgical kits streamlines intraoperative workflows and reduces setup variability. Viscoelastic agents play a crucial role in canaloplasty procedures, and distinctions between cohesive viscoelastics and dispersive viscoelastics matter clinically; cohesive agents facilitate canal expansion and removal in a single sweep, whereas dispersive formulations may confer more tissue protection in complex anatomy, influencing clinician choice depending on the case profile.

Technique segmentation further differentiates market needs. Ab Externo approaches remain relevant for certain anatomies and surgeon preferences, but the rapid ascent of Ab Interno techniques-especially those leveraging microinvasive approaches-has broadened adoption among anterior segment surgeons who favor reduced invasiveness and faster postoperative recovery. End-user segmentation underlines where procedural adoption surfaces in the healthcare delivery chain: ambulatory surgical centers, both affiliated and independent, are key venues for high-throughput minimally invasive procedures; hospitals, whether private or public, continue to support more complex cases and training; and ophthalmology clinics, including chain networks and independent practices, are increasingly integrating procedural offerings alongside clinical management. Distribution channel dynamics are similarly nuanced. Direct sales remain critical for high-touch, capital-intensive accounts that require training and clinical support, whereas distributor sales, routed through original equipment distributors or value added resellers, enable broader geographic reach and flexible inventory management. Clinical indications also shape clinical pathways and procurement priorities. Primary open angle glaucoma remains the predominant indication driving procedural volume, while secondary glaucomas, such as neovascular and pigmentary glaucoma, create demand for tailored approaches and adjunctive products. Finally, age group segmentation underscores distinct clinical considerations across adult, geriatric, and pediatric patients, with geriatric cohorts presenting comorbidity patterns that influence perioperative planning and device selection.

Comparative regional evaluation that clarifies where reimbursement frameworks, clinical infrastructure, and distribution ecosystems most strongly influence canaloplasty adoption and supplier strategy

Regional dynamics vary significantly and influence where investment, clinical education, and supply chain optimization yield the greatest returns. In the Americas, mature reimbursement frameworks and established ambulatory surgical infrastructure support rapid adoption of minimally invasive canaloplasty options, yet this region also faces concentrated cost pressures that shift purchasing toward bundled solutions and cost-effective consumables. Europe, Middle East & Africa presents a heterogeneous landscape: select European markets exhibit advanced regulatory pathways and broad procedural uptake, while pockets across the Middle East and Africa show emerging centers of excellence that prioritize training and technology transfer programs to build local capacity. In these geographies, partnerships with local distributors and investment in clinician education are pivotal to scaling procedural volumes.

Asia-Pacific spans highly developed markets with sophisticated hospital systems and rapidly expanding ambulatory networks, as well as emerging economies where access to specialty devices is improving. In well-resourced APAC markets, there is a premium on innovation and evidence generation to support differentiated product positioning, whereas in growth markets, affordability and supply chain reliability drive procurement. Across regions, regulatory nuances, reimbursement mechanisms, and the distribution ecosystem shape timing and pathways for clinical adoption. As a consequence, a region-aware commercial playbook that aligns product configurations, training investments, and distributor engagement strategies is essential to capture opportunity while managing operational risk.

Competitive dynamics and partnership models that distinguish established multi-portfolio firms, specialized innovators, and channel partners driving adoption and scale in canaloplasty

The competitive landscape is characterized by a mix of established medical device firms with broad ophthalmic portfolios and focused innovators that specialize in microinvasive glaucoma surgery technologies. Established players leverage clinical trial networks, surgeon training programs, and integrated service models to protect high-value accounts and to position comprehensive procedural solutions. Focused device firms, on the other hand, concentrate on differentiated catheter designs, single-use surgical kits, or novel viscoelastic chemistries to gain clinical traction and to command premium positioning among early adopters.

Complementing these manufacturers, contract manufacturers and high-quality component suppliers play an instrumental role in bringing complex microdevice designs to market quickly and at scale. Similarly, distributor partners, whether original equipment distributors or value added resellers, contribute localized market knowledge, aftermarket service, and channel flexibility. Strategic collaborations between technology owners and distribution partners are increasingly common, enabling rapid geographic expansion while reducing direct operating burden. Finally, service-oriented entrants that bundle training, outcomes tracking, and procedural support are differentiating by promising faster adoption cycles and better real-world outcomes documentation, thereby appealing to health systems prioritizing clinical governance and quality assurance.

Actionable strategic priorities for manufacturers and channel partners focused on evidence generation, adaptive commercial models, and resilient supply chain design to accelerate adoption

Industry leaders should prioritize a combination of clinical evidence generation, supply chain resilience, and differentiated commercial models to sustain momentum. Investing in prospective registries and collaborative real-world evidence programs will help validate outcomes across diverse indications, including primary open angle glaucoma and challenging secondary glaucomas such as neovascular and pigmentary etiologies. These efforts should be synchronized with targeted clinician education initiatives that emphasize technique nuances between Ab Externo and Ab Interno approaches and the practical implications of choosing cohesive versus dispersive viscoelastic agents.

On the commercial front, organizations would benefit from tailoring engagement models to end-user segmentation. High-touch accounts in hospital systems and affiliated ambulatory surgical centers often require direct sales engagement, hands-on training, and bundled service arrangements, whereas broader geographic coverage can be achieved through distributor sales that leverage original equipment distributors and value added resellers. Operationally, companies should diversify manufacturing and component sourcing to mitigate tariff and trade risks, while exploring nearshoring or regional assembly strategies that preserve margin and delivery reliability. Finally, aligning product roadmaps with age-specific clinical needs and with the procedural preferences of high-volume surgeons will strengthen reimbursement dialogues and differentiate offerings in competitive tenders.

Methodological framework describing primary clinician and stakeholder interviews complemented by secondary regulatory and clinical literature reviews with multi-axis segmentation analysis

The research methodology underpinning this analysis combined qualitative and quantitative approaches to construct a robust understanding of canaloplasty dynamics. Primary research included structured interviews with practicing glaucoma surgeons, ambulatory surgical center administrators, hospital procurement officers, and distributor partners to capture firsthand perspectives on procedure selection, device preferences, and service expectations. These interviews were complemented by secondary research that synthesized regulatory guidance, procedural coding frameworks, and published clinical literature to triangulate clinical adoption drivers and to verify comparative device attributes.

Analytical frameworks used in the study emphasized segmentation across product types, techniques, end-user settings, distribution channels, clinical indications, and patient age groups to surface actionable insights. Supply chain and policy impact analysis incorporated trade policy review, procurement practices, and supplier capability assessments. Where applicable, sensitivity checks and cross-validation against clinician feedback ensured that conclusions reflect operational realities and the practical constraints encountered by adopters in diverse geographies.

A strategic synthesis emphasizing the imperative for evidence, training, and operational resilience to convert clinical innovation in canaloplasty into sustained clinical adoption

In summary, canaloplasty represents an intersection of device innovation, procedural evolution, and shifting care delivery models that together create substantial strategic implications for manufacturers, distributors, and clinical institutions. The landscape favors organizations that can combine robust clinical evidence, clinician training, and flexible commercial channels while maintaining supply chain adaptability in the face of trade policy changes and regional regulatory complexity. Attention to product differentiation-particularly in microcatheter performance, surgical kit design, and viscoelastic properties-will continue to influence clinician preference and procedural uptake.

Moving forward, stakeholders that invest in partnership models, targeted real-world evidence programs, and regionally optimized go-to-market strategies will be best positioned to translate clinical promise into enduring adoption. Coordinated efforts that align innovation, reimbursement engagement, and operational resilience will be essential to meet the nuanced needs of diverse patient cohorts and care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of minimally invasive canaloplasty with MIGS to reduce intraocular pressure in glaucoma patients
  • 5.2. Development of sustained-release viscoelastic implants for improved canal remodeling and long-term IOP control
  • 5.3. Adoption of advanced imaging-guided navigation systems to enhance precision in canaloplasty procedures
  • 5.4. Surge in physician training programs focusing on microincision canaloplasty techniques to boost adoption rates
  • 5.5. Rising investments in drug-eluting stents post canaloplasty to prevent postoperative fibrosis and maintain canal patency
  • 5.6. Growing collaborations between device manufacturers and academic institutions to innovate canaloplasty tools and materials

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Canaloplasty Market, by Product Type

  • 8.1. Microcatheters
  • 8.2. Surgical Kits
  • 8.3. Viscoelastic Agents
    • 8.3.1. Cohesive Viscoelastic
    • 8.3.2. Dispersive Viscoelastic

9. Canaloplasty Market, by Technique

  • 9.1. Ab Externo
  • 9.2. Ab Interno
    • 9.2.1. Microinvasive Approach

10. Canaloplasty Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Affiliated Centers
    • 10.1.2. Independent Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Ophthalmology Clinics
    • 10.3.1. Chain Clinics
    • 10.3.2. Independent Clinics

11. Canaloplasty Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales
    • 11.2.1. Original Equipment Distributors
    • 11.2.2. Value Added Resellers

12. Canaloplasty Market, by Indication

  • 12.1. Primary Open Angle Glaucoma
  • 12.2. Secondary Glaucoma
    • 12.2.1. Neovascular Glaucoma
    • 12.2.2. Pigmentary Glaucoma

13. Canaloplasty Market, by Age Group

  • 13.1. Adult
  • 13.2. Geriatric
  • 13.3. Pediatric

14. Canaloplasty Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Canaloplasty Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Canaloplasty Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Nova Eye Medical, Inc.
    • 17.3.2. Sight Sciences, Inc.
    • 17.3.3. Glaukos Corporation
    • 17.3.4. Sight Sciences, Inc.
    • 17.3.5. Ellex Medical Lasers Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CANALOPLASTY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CANALOPLASTY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CANALOPLASTY MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CANALOPLASTY MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CANALOPLASTY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS CANALOPLASTY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL CANALOPLASTY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL CANALOPLASTY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. CANALOPLASTY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. CANALOPLASTY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CANALOPLASTY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CANALOPLASTY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CANALOPLASTY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CANALOPLASTY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CANALOPLASTY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CANALOPLASTY MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CANALOPLASTY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CANALOPLASTY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS CANALOPLASTY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS CANALOPLASTY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS CANALOPLASTY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS CANALOPLASTY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS CANALOPLASTY MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE CANALOPLASTY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE CANALOPLASTY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE CANALOPLASTY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPE CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPE CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPE CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPE CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPE CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2025-2032 (USD MILLION)
  • TABLE 335. EUROPE CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 336. EUROPE CANALOPLASTY MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPE CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPE CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPE CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 340. EUROPE CANALOPLASTY MARK